Edgewise Therapeutics, Inc. · NASDAQ:EWTX

Paradigm Biocapital Advisors LP reported a 5.00% stake in Edgewise Therapeutics, Inc. (Schedule 13G)

Event Jan 27, 2025 · Filed Feb 3, 2025

Paradigm Biocapital Advisors LP reported a 5.00% stake in Edgewise Therapeutics, Inc., 4,738,929 shares, as a passive investor on Jan 27, 2025. Filed Feb 3, 2025 (Schedule 13G).

Stake
5.00%
Shares
4,738,929
Intent
Passive
What changed
Crossed above 5%
Filed together
4 holders

The filing in full

HolderStakeShares
Paradigm BioCapital Advisors LP5.00%4,738,929
Paradigm BioCapital Advisors GP LLC5.00%4,738,929
Senai Asefaw, M.D.5.00%4,738,929
Paradigm BioCapital International Fund Ltd.4.40%4,181,497

Source

View original at SEC

Related